Triggered Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (10 May 2020) | Viewed by 9247
Special Issue Editor
Interests: translational nanomedicine; controled release; biocompatible materials; targeting; optical ion sensing; hyperthermia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The maturing of the field of nanotechnology has allowed in the last decades the development of a wide variety of solutions to biomedical problems, in particular in the fields of drug delivery and sensing. However, a large volume of this research is focused on passive delivery, such as acummulation of the nanocarriers at the site of interest, but without having a precise control on the time of the activation or drug release dosage of the nanomaterial. A strategy which may enhance the effectivity of the diagnostic or the treatment, but that fails to address the need of removing its side effects to other tissues or biological sites and that it does not benefit from the economical advantage of requiring smaller amounts of the drug.
In recent years, there has been a growing effort to research smart and autonomous nanomaterials that activate only under endogenous or exogenous stimuli, either as nanocarriers or as the active entities themselves. The aim of this effort is to design nanosystems that allow tailored interventions, either by displaying on-demand activation in response to certain biomarker levels, or by allowing its activation through externally controlled stimuli.
This special issue is a compilation of recent advances in nanomaterials which allow stimuli-responsive triggered drug release and sensing.
Prof. Dr. Pilar Rivera-Gil
Dr. Muriel Rovira-Esteva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
